General form of registration statement for all companies including face-amount certificate companies

CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)

v2.4.0.8
CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) (USD $)
 3 Months Ended 12 Months Ended
Mar. 31, 2014
Mar. 31, 2013
Dec. 31, 2013
Dec. 31, 2012
CASH FLOWS FROM OPERATING ACTIVITIES:        
Net Loss $ (4,916,490) $ (1,548,370) $ (6,148,350) $ (5,836,369)
Adjustments to reconcile net loss to net cash used in operating activities:        
Gain on fair market valuation of derivatives 1,284,825    (673,000)   
Depreciation and amortization 92,982 3,070 41,309 14,088
Loss on disposal of property and equipment          1,322
Warrants issued with common stock 1,249,123 185,630 1,355,990 135,400
Stock issued for interest expense    55,777 1,039,081   
Stock issued for services    309,048 773,165   
Equity instruments issued with debt greater than debt carrying amount 1,214,000 718,000 2,054,000   
Preferred Stock issued for compensation    (5,000)    200,000
Impairment of goodwill          4,799,965
Change in accounts receivable and inventory reserve     359,126 79,534
Changes in operating assets and liabilities:        
Accounts receivable 33,867 31,695 (41,450) (74,629)
Inventory    (2,709) (75,389) 258,300
Prepaid expenses     (857)   
Prepaid inventory     51,988 (37,212)
Note receivable     (173,754)   
Deposits 4,550 (508,000) (3,388,887) 5,000
Accounts payable (458,001) (50,431) 973,441 207,176
Due to officers        (500)
Net cash used in operations (1,495,144) (811,290) (3,853,587) (247,925)
CASH FLOWS FROM INVESTING ACTIVITIES:        
Proceeds from sale of property and equipment        6,293
Purchase of property and equipment (1,332,024)       (534)
Purchase of intangible assets     (11,400)   
Cash assumed in acquisition     100  
Cash assumed in reverse merger        35
Net cash used in investing activities (1,332,024)    (11,300) 5,794
CASH FLOWS FROM FINANCING ACTIVITIES:        
Proceeds from issuance of notes payable 1,984,210 928,474 2,403,474 264,306
Proceeds from issuance of notes payable to related parties 27,500 17,502 17,502 44,190
Payment on notes payable (300,000)    (100,000) (150,000)
Payments on notes payable to related parties (130,000) (5,000) (20,000) (89,192)
Proceeds from issuance of common stock and warrants and common stock subscribed 4,014,919 290,160 1,574,542 180,000
Proceeds from issuance of common stock from the exercise of warrants 173,420       
Net cash provided by financing activities 5,770,049 1,231,136 3,875,518 249,304
NET CHANGE IN CASH AND CASH EQUIVALENTS 2,942,881 419,846 10,631 7,173
CASH AND CASH EQUIVALENTS, beginning of period 26,943 16,312 16,312 9,139
CASH AND CASH EQUIVALENTS, end of period 2,969,824 436,158 26,943 16,312
SUPPLEMENTAL DISCLOSURE FOR OPERATING ACTIVITES        
Cash paid for interest 95,676 2,250 13,500   
SUPPLEMENTAL DISCLOSURE FOR FINANCING ACTIVITIES        
Warrant expense $ 1,249,123 $ 185,630 $ 1,355,990 $ 135,400